COVID-19 Funding Snapshot for Pharma Developers/Manufacturers Views as of August 7, 2020 Presentations August 21, 2020 Lain Anderson Cassie Guo Adam Nover
Contributing authors: Tony Stripling, Associate Consultant Sean Saunders, Life Sciences Speciaist Jennifer Henry, Associate Consultant Patrick Marquet, Associate Related Practice Life Sciences & Pharma The COVID-19 pharmaceutical funding landscape is evolving at a rapid pace, yet several initial insights have emerged 01262022160100
Smart Chart Life Sciences & Pharma Radiotherapeutics on the Rise: Cracking the Supply Chain Code May 16, 2025
Smart Chart Life Sciences & Pharma Look Forward 2025: Proving AI’s Value in Life Sciences January 22, 2025
Executive Insights Life Sciences & Pharma Understanding the Inflation Reduction Act Negotiation Prices After the Dust Has Settled September 27, 2024
Video / Webinar Life Sciences & Pharma Contrasting China's Market Dynamics with Global Pharma Giants August 16, 2024